Benzinga | Mar 16, 2021 07:19AM EDT

Cogent Biosciences Q4 Sales $7.87M Down From $22.50M YoY

Cogent Biosciences (NASDAQ:COGT) reported $7.87 million in sales this quarter. This is a 65.02 percent decrease over sales of $22.50 million the same period last year.